High Affinity Ca2+ Binding Sites of Calmodulin Are Critical for the Regulation of Myosin Ibeta Motor Function*

Tong Zhu, Kathy BeckinghamDagger , and Mitsuo Ikebe§

From the Department of Physiology, University of Massachusetts Medical Center, Worcester, Massachusetts 01655 and Dagger  Department of Biochemistry and Cell Biology, Rice Univesity, Houston, Texas 77005

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

We coexpressed myosin Ibeta heavy chain with three different calmodulin mutants in which the two Ca2+-binding sites of the two N-terminal domain (E12Q), C-terminal domain (E34Q), or all four sites (E1234Q) are mutated in order to define the importance of these Ca2+ binding sites to the regulation of myosin Ibeta . The calmodulin mutated at the two Ca2+ binding sites in N-terminal domain and C-terminal domain lost its lower affinity Ca2+ binding site and higher affinity Ca2+ binding site, respectively. We found that, based upon the change in the actin-activated ATPase activities and actin translocating activities, myosin Ibeta with E12Q calmodulin has the regulatory characteristics similar to myosin Ibeta containing wild-type calmodulin, while myosin Ibeta with E34Q or E1234Q calmodulin lose all Ca2+ regulation. While the increase in myosin Ibeta ATPase activity paralleled the dissociation of 1 mol of calmodulin from myosin Ibeta heavy chain for both wild type (above pCa 5) and E12Q calmodulin (above pCa 6), the Ca2+ level required for the inhibition of actin-translocating activity of myosin Ibeta was lower than that required for dissociation of calmodulin, suggesting that the conformational change induced by the binding of Ca2+ at the high affinity site but not the dissociation of calmodulin is critical for the inhibition of the motor activity. Our results suggest that the regulation of unconventional myosins by Ca2+ is directly mediated by the Ca2+ binding to calmodulin, and that the C-terminal pair of Ca2+-binding sites are critical for this regulation.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Myosins are a large family of molecular motors responsible for diverse forms of cell contractility and motility, such as muscle contraction, chemotaxis, and phagocytosis (1). Myosin I, one of the 14 classes of this myosin superfamily, is single-headed and unable to form filaments (1-4). Based on the similarity of their primary structures in the head domain, myosin Is are further classified into four subclasses. Myosin Ibeta is one of these subclasses (1, 4).

Myosin Ibeta was first purified from bovine adrenal gland and brain (5). Subsequently, cDNAs encoding myosin Ibeta were isolated from bovine adrenal gland (6), bovine brain (7), and neonatal rat brain (8). Myosin Ibeta was found in a variety of tissues with the highest expression levels in heart, lung, adrenal gland, esophagus, and stomach (6, 7, 9, 10). Myosin Ibeta localizes to actin-rich peripheral structures, such as filopodia and lamellipodia of culture cells (9), and it is thought to play a role in cytoskeleton rearrangement. Interestingly, myosin Ibeta is also found in hair bundles purified from the bullfrog sacculus, suggesting that myosin Ibeta may function as an adaptation motor which regulates the tip link-associated cation selective channels (11, 12).

Studies from both naturally isolated and recombinant myosins Ibeta have shown that calmodulin is associated with myosin Ibeta heavy chain (5, 13). In contrast to most calmodulin-dependent enzymes, the association of calmodulin with myosin I does not require Ca2+ binding to calmodulin. Thus, calmodulin functions as a light chain subunit. Myosin Ibeta , like all the other vertebrate unconventional myosins, has several repeats of a 24-30-amino acid sequence called the IQ motif at the neck region between the myosin head motor domain and the tail domain. This motif has been suggested to provide the binding site for EF-hand family proteins such as calmodulin (1, 14). All vertebrate unconventional myosins that have been characterized so far contain calmodulin as light chains. For some unconventional myosins, other small proteins besides calmodulin have also been found to function as light chains (15). A common property of calmodulin targets that contain IQ motif, such as the unconventional myosins and neuromodulin, is that they have a higher affinity for the Ca2+-free form of calmodulin (16).

Calmodulin is one of the major intracellular Ca2+-sensor proteins, containing four EF-hand type Ca2+-binding loops. The N-terminal pair are linked to the C-terminal pair by a central flexible linker. Among the four Ca2+-binding sites, the C-terminal pair of Ca2+-binding sites have a higher Ca2+-binding affinity than those of the N terminus (17, 18). Ca2+ binding induces structural changes in calmodulin, and it is believed that these Ca2+-induced conformational changes allow calmodulin to activate target enzymes when the cytosolic Ca2+ concentration is elevated (reviewed in Ref. 19). Mutagenesis studies have shown that a conserved glutamic acid residue at the 12th position of each Ca2+-binding loop is critical for Ca2+ binding, and substitution of this conserved glutamic acid with glutamine in each Ca2+-binding site abolishes its Ca2+ binding ability (17, 20).

Both the enzymatic and mechanical activities of vertebrate myosin I have been shown to be regulated by Ca2+ (5, 13, 21-23), and this is also true for other unconventional myosins, such as myosin V (15). A member of another myosin I subclass, intestinal brush-border myosin I (BBMI),1 has been extensively characterized in terms of Ca2+ effects. It was found that BBMI moved actin filaments although the velocity was quite low (~0.05 µm/s), and the activity was abolished at Ca2+ concentrations above 5 µM. On the other hand, actin-activated Mg2+-ATPase activity of BBMI increased with increasing Ca2+ concentrations (24). Interestingly, partial dissociation of calmodulin from BBMI was observed at a Ca2+ concentration of 10 µM. Similarly, Zhu et al. (13) have shown that one of the three calmodulin molecules bound to recombinant myosin Ibeta dissociated from the heavy chain at a Ca2+ concentration of 10 µM. While Mg2+-ATPase activity increased above pCa 6, actin sliding velocity of myosin Ibeta was abolished at pCa 6 (13). These results suggest that Ca2+ binding to the calmodulin light chains is critical for the regulation of vertebrate myosin I motor function. However, it is unclear whether the dissociation of calmodulin is necessary to stop myosin I motor activity since the Ca2+ concentration required for the dissociation of one calmodulin from myosin Ibeta heavy chain seems to be higher than the Ca2+ concentration for inhibition of the actin translocating activity (13).

In the present study, we have examined the mechanism by which Ca2+ and calmodulin regulate myosin Ibeta motor function by coexpressing various calmodulin mutants defective in Ca2+ binding with myosin Ibeta heavy chain and analyzing the actin-activated ATPase activity and motor function of the expressed myosin Ibeta .

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Expression of Bovine Myosin Ibeta Together with Mutant Calmodulin in Sf9 Cells-- Expression of bovine myosin Ibeta cDNA with calmodulin was performed as described previously (13). cDNA for wild-type calmodulin and calmodulin with the two N-terminal, two C-terminal, or all four Ca2+-binding sites mutated, termed E12Q, E34Q, and E1234Q, respectively (25), were subcloned into pBlueBacM baculovirus transfer vector at the EcoRI site in the polylinker region. Orientation and accuracy of the subcloning were examined by DNA sequencing (Sequenase 2.0, U. S. Biochemical Corp.). Recombinant baculoviruses containing these mutant calmodulin cDNAs were obtained by blue plaque selection and subsequent steps of purification and amplification as described in the manual from Invitrogen, MaxBac Baculovirus Expression System. Sf9 cells were coinfected with the recombinant viruses of myosin Ibeta heavy chain and each calmodulin mutant.

Purification of Recombinant Myosin Ibeta with Mutant Calmodulin-- The purification of recombinant myosin Ibeta was performed as previously with slight modifications (13). Briefly, cells were harvested after 3 days of culture at 28 °C and lysed in the presence of ATP, Triton X-100, Nonidet P-40, and various protease inhibitors. The supernatant (150,000 × g for 30 min) of lysed cells was incubated with 10 mM glucose and 20 units/ml hexokinase at 0 °C for 30 min to completely hydrolyze residual ATP. F-actin (1 mg/ml) was added to coprecipitate the expressed myosin Ibeta . The pellet was resuspended with buffer containing 5 mM MgCl2, 100 mM KCl, 1 mM EGTA, and 25 mM Tris-HCl, pH 7.5, and 1 mM ATP was added to release myosin Ibeta from the myosin I-actin complex. The sample was ultracentrifuged at 150,000 × g for 30 min to remove F-actin, and the supernatant containing the expressed myosin Ibeta heavy chain and calmodulin was subject to a DE52 column (1 × 10 cm). The protein was eluted with a linear gradient (12 ml-12 ml) of 50-250 mM KCl. Approximately 100 µg of myosin Ibeta can be obtained from 800 ml of culture.

Expression and Purification of Calmodulin Mutants-- Wild-type calmodulin and mutant proteins were expressed by infecting Sf9 cells with recombinant virus. Cells were homogenized with 5 volumes of buffer A (30 mM Tris-HCl, pH 7.5, 8 M urea, 5 mM dithiothreitol, 10 µg/ml leupeptin) for 5 min. After centrifugation at 35,000 × g for 15 min, 5% trichloroacetic acid was added to the supernatant. The pellets were collected and suspended with M urea, and the pH was adjusted to be neutral. The suspension was dialyzed against buffer B (30 mM Tris-HCl, pH 7.5, 1 mM dithiothreitol) for 2 h. After insoluble material was removed by centrifugation, the sample was loaded to a DE52 ion exchange column (24 × 3 cm) equilibrated with buffer B. Calmodulin was eluted with a 0-0.4 M NaCl linear gradient. The fractions containing calmodulin were combined, concentrated, and loaded onto a Sephacryl S200 gel filtration column (100 × 3 cm). The fractions containing calmodulin were identified by SDS-polyacrylamide gel electrophroesis analysis. They were combined and concentrated. The concentrated calmodulin was dialyzed against buffer C (30 mM Tris-HCl, pH 7.5, 30 mM NaCl, 1 mM dithiothreitol) and stored in -80 °C. Bacterially expressed wild type and mutant calmodulins were prepared as described previously (25).

Fluorimeter Titrations-- Ca2+-induced conformational changes in calmodulins were determined by Ca2+ titrations in the presence of 9-anthroylcholine (9-AC) according to Beckingham with some modifications (20). Purified calmodulin was dialyzed extensively against the titration buffer (0.5 mM CaCl2, 100 mM KCl, and 10 mM MOPS, pH 7.0). 2-ml titration buffer containing 5 µM of such prepared calmodulin and 20 µM of 9-AC bromide (Molecular Probes, Eugene, OR) were transferred to a quartz cuvette, and fluorescence measurements were made as sequential addition of small volume (1 to several microliters) EGTA solutions (20 mM, 200 mM, or 1 M). The amount of EGTA was added so that the concentrations of free Ca2+ in the cuvette were the desired ones (26). The fluorescence intensity was measured by using a Spex Fluorolog fluorimeter (Spex Inc., Edison, NJ) with excitation at 366 nm and emission at 418 nm. The pH of the samples was examined both before and after titration.

ATPase Assays and Other Biochemical Procedures-- The effect of Ca2+ on actin-activated ATPase activity was assayed in 30 mM KCl, 2 mM MgCl2, 20 mM imidazole-HCl, pH 7.0, with or without 50 µM actin, in the presence of 1 mM EGTA or various concentrations of Ca2+ (26). All assays were initiated by adding 100 µM [gamma -32P]ATP (Amersham Corp.) to the reaction mix. The liberated 32P was measured as described previously (27) to determine ATPase activity.

The effect of Ca2+ on the binding of calmodulin to myosin Ibeta heavy chain was determined as follows: myosin Ibeta was dialyzed against different Ca2+ buffers in the absence of ATP, and the sample was ultracentrifuged at 150,000 × g for 30 min in the presence of 1 mg/ml F-actin. Then the pellet was analyzed by SDS-polyacrylamide gel electrophroesis. The amount of the cosedimented myosin Ibeta and calmodulin was determined by densitometry, using a Macintosh computer equipped with a frame grabber (LG-3, Scion Corp., Walkersville, MD) connected to a video camera (Pulnix, TM-745, Motion Analysis, Inc., Eugene, OR), and the software used was NIH Image 1.56b18 (Bethesda, MD).

All experiments were carried out at 25 °C, and all the results are represented by mean ± S.E.

In Vitro Motility Assay-- In vitro motility assays were performed as described previously (28). A larger nitrocellulose-coated coverslip (24 × 30 mm) was covered by smaller coverslip (18 × 18 mm), each edge of which was applied with 0.1 g of silicon grease (Dow Corning, MI), to create a fluid-filled flow cell. After 60 µl of myosin I-containing solution was applied to the flow cell, unbound myosin I was washed away with 180 µl of buffer A (400 mM KCl, 25 mM HEPES, pH 7.5, 4 mM MgCl2, and 10 mM dithiothreitol). Then the unoccupied nitrocellulose surface was coated with 0.5 mg/ml bovine serum albumin in buffer B (30 mM KCl, 20 mM HEPES, 1 mM EGTA, pH 7.5). The flow cell was washed with buffer B, then rhodamine-phalloidin (Molecular Probes Inc., Eugene, OR) labeled actin filaments in the motility buffer (50 mM KCl, 5 mM MgCl2, 25 mM imidazole, 1 mM EGTA, 1% 2-mercaptoethanol, 0.5% methylcellulose, 4.5 mg/ml glucose, 216 µg/ml glucose oxidase, 36 µg/ml catalase) with various concentrations of Ca2+ were introduced onto the myosin-coated coverslip. After 120 µl of motility buffer were perfused to wash out unbound actin filaments, motility buffer containing Mg2+-ATP was applied to initiate the reaction. Movements of fluorescent actin filaments were observed using an inverted fluorescence microscope (Diaphot, Nikon) with a SIT camera (VE 1000 SIT, DAGE MTI) and a video cassette recorder. The actin sliding velocity was determined as described previously (13).

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Three different calmodulin Ca2+ binding site mutants, termed E12Q, E34Q, and E1234Q (25), were used in this study. In each protein, particular Ca2+-binding sites were inactivated by mutation of a conserved glutamate residue (at position 12 of the Ca2+-binding loops) to glutamine. In E12Q the two N-terminal sites were mutated, in E34Q the two C-terminal sites were mutated, and in E1234Q, all four sites carried the mutation.

Wild-type calmodulin and each of the calmodulin mutants was coexpressed with myosin Ibeta heavy chain in insect Sf9 cells, and the expressed myosin Ibeta was isolated. All of the calmodulin mutants copurified with myosin Ibeta heavy chain, suggesting that the mutations do not affect the binding of calmodulin to myosin Ibeta heavy chain. The ability of Ca2+ to increase electrophoretic mobility, a characteristic of wild-type calmodulin, was examined for each of these three mutants (Fig. 1). Wild type calmodulin migrated with an apparent molecular mass of 16 kDa in 5 mM Ca2+ but with an apparent molecular mass of 21 kDa in the presence of 1 mM EGTA. E12Q calmodulin mutant migrated at 22 kDa in EGTA but at 19 kDa in the presence Ca2+. On the other hand, E34Q migrated at 21 and 18 kDa in the absence and presence of Ca2+, respectively. The mobility shift by Ca2+ was abolished with E1234Q calmodulin mutant, which migrated at 21 kDa under both conditions. These results confirm that the calmodulin light chain associated with the myosin Ibeta heavy chain in each preparation is indeed the expressed recombinant calmodulin mutant, and not endogenous calmodulin. They also suggest that the effect of mutating the two N-terminal Ca2+ binding sites on the conformational change of calmodulin is different from that of mutating the two C-terminal sites.


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 1.   Electrophoretic mobility shift of calmodulin mutants in the presence of EGTA or Ca2+ conditions. Myosin Ibeta (before DE52 chromatography) was applied to SDS-polyacrylamide gel electrophoresis under 1 mM EGTA (lanes 3, 5, 7, and 9) or 5 mM CaCl2 (lanes 2, 4, 6, and 8) conditions. Large and small arrowheads represent myosin Ib heavy chain and calmodulin, respectively. Molecular mass standards are indicated in lane 1. Lanes 2 and 3, wild type; lanes 4 and 5, E12Q; lanes 6 and 7, E34Q; and lanes 8 and 9, E1234Q.

Ca2+-induced conformational changes in the calmodulin mutants were further monitored as a function of Ca2+ concentration by use of the reporter molecule 9-AC bromide. The Ca2+-induced appearance of hydrophobic sites on calmodulin is revealed by the enhanced fluorescence of 9-AC upon binding to these sites, and this technique has been used previously to examine the Ca2+ binding and conformational properties of Ca2+ binding site mutants of calmodulin (20). The 9-AC fluorescence enhancement for wild type calmodulin as a function of Ca2+ concentration is shown in Fig. 2. A single transition is detected, with midpoint at a Ca2+ concentration (10-7) that is lower than the dissociation constant for the high affinity sites on calmodulin. This finding probably reflects increased overall affinity for Ca2+ and increased cooperativity of Ca2+ binding induced by 9-AC. The hydrophobic reporter 1-anilino-8-naphtalene sulfonate has been shown previously to increase the affinity of calmodulin for Ca2+ (29). The curve for the E12Q (see Fig. 2) is very similar to the wild type curve at low Ca2+ concentrations but shows no increase in fluorescence enhancement at Ca2+ concentrations above pCa 6. This is consistent with induction of a conformational change as a result of Ca2+ binding to the two intact C-terminal sites present on this protein followed by absence of Ca2+ binding and the associated conformational change in the N-terminal domain. In contrast, the E34Q mutant shows no fluorescence enhancement at low Ca2+ and relatively minor enhancement of fluorescence with a midpoint at about pCa 6 as Ca2+ levels are increased. Thus a major conformational change normally associated with C-terminal high affinity sites is lost in the E34Q mutant leaving a smaller conformational change associated Ca2+ binding in the intact N-terminal domain. The sum of the fluorescence changes for E12Q and E34Q equals the changes for the wild type calmodulin (Fig. 2). The E1234Q mutant showed no change in 9-AC fluorescence throughout the entire pCa range tested (data not shown).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Binding of Ca2+ to calmodulin as a function of Ca2+ concentration. Binding of Ca2+ to calmodulin was monitored by measuring 9-anthroylcholine bromide fluorescence curves of EGTA titration of wild-type and mutant calmodulin. Calmodulin in 0.5 mM Ca2+ is titrated by addition of EGTA. pH values were 7.04 prior to titration and 7.07 at the end of titration. , wild type; diamond , E12Q; open circle , E34Q

The actin-activated Mg2+-ATPase activity of myosin is coupled to actomyosin cross-bridge turnover. In order to examine the effect of Ca2+ binding at the N- and C-terminal sites of calmodulin on myosin Ibeta mechanoenzymatic function, actin-activated Mg2+-ATPase activity of myosin Ibeta containing the mutant calmodulins was measured as a function of Ca2+ (Fig. 3). For all assays, the timecourse of Pi liberation was determined and the activity was estimated from the slope of the Pi release timecourse. Unlike myosin Ibeta -containing wild-type calmodulin, for which Mg2+-ATPase activity increased in both the absence and presence of F-actin with Ca2+ concentration above pCa 6 (Fig. 3A), myosin Ibeta -containing mutant calmodulin showed different Ca2+ dependencies. The ATPase activity of E12Q myosin Ibeta started to increase below pCa 6 and reached maximum at pCa 6 (Fig. 3B). On the other hand, the ATPase activities of myosin Ibeta containing both E34Q and E1234Q mutants did not show any Ca2+ dependence (Fig. 3, C and D). The activity of myosin Ibeta containing these two mutant calmodulins was similar to that of myosin Ibeta with wild-type calmodulin in EGTA, suggesting that Ca2+ binding to calmodulin in the C-terminal domain induced the enhancement of ATPase activity. These data suggest that the Ca2+-dependence of actin-activated ATPase activity of myosin Ibeta is mediated through Ca2+ binding to calmodulin and that the two C-terminal Ca2+-binding sites (high affinity sites) have a more important role in the Ca2+ sensitivity of myosin Ibeta ATPase activity.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of Ca2+ on actin-activated ATPase activity of myosin Ibeta containing various calmodulin mutants as its light chains. Actin-activated ATPase activity is assayed with 20 µg/ml in reaction buffers of different pCa in the absence of actin (), or in the presence of 50 µM actin (diamond ) (n = 3). The error bars of several points are within the symbols. A, wild type; B, E12Q; C, E34Q; and D, E1234Q.

To access the effects of mutating the N- and C-terminal Ca2+-binding sites of calmodulin on myosin Ibeta motor activity, actin sliding velocity was measured by the in vitro motility assay system (Table I). Wild-type, E12Q, E34Q, and E1234Q myosin Ibeta were all able to translocate actin filament at a rate about 0.3 µm/s in the presence of EGTA. The value agrees well with the one reported in the previous study (13). While switching motility buffer from 1 mM EGTA to 1 or 10 µM Ca2+ abolished the actin filament movement for wild-type and E12Q myosin Ibeta , it had little effect on the motility activity of E34Q and E1234Q myosin Ibeta . These results suggest that the Ca2+ regulation of motor activity of myosin Ibeta is also mediated through the binding of Ca2+ to calmodulin. They further demonstrate that the two C-terminal Ca2+-binding sites but not the two N-terminal sites are critical for this regulation.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Ca2+ dependence of actin filament sliding velocity of myosin Ibeta with different calmodulin mutants

The effects of Ca2+ on the binding of the various calmodulins to myosin Ibeta heavy chain were also examined (Fig. 4). Purified myosin Ibeta containing each calmodulin mutant was coprecipitated with F-actin at various Ca2+ concentrations, and the precipitated myosin Ibeta and calmodulin were subjected to SDS-polyacrylamide gel electrophroesis followed by densitometry analysis to quantify the stoichiometry of the bound calmodulin. It is known that 3 mol of calmodulin bind to 1 mol of myosin Ibeta heavy chain (13). For wild-type calmodulin, one of the three molecules of bound calmodulin was dissociated from the heavy chain above pCa 5 (Fig. 4A). On the other hand, for E12Q myosin Ibeta , the dissociation of calmodulin was observed at lower Ca2+ (i.e. pCa 6) (Fig. 4B). In contrast, Ca2+ had no effect on the binding of E34Q calmodulin, i.e. all three calmodulin molecules were associated with the heavy chain even at pCa 4 (Fig. 4C). As expected, the binding of E1234Q mutant calmodulin to the heavy chain showed no Ca2+ sensitivity (Fig. 4D).


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of Ca2+ on association of calmodulin with myosin Ibeta heavy chain. Molar ratio of calmodulin to myosin Ibeta heavy chain under different pCa conditions is determined according to "Materials and Methods" (n = 2). A, wild type; B, E12Q; C, E34Q; and D, E1234Q.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

In this study, we have coexpressed myosin Ibeta heavy chain with three different calmodulin mutants, in which the conserved critical glutamic acid residue at the 12th position of the two N-terminal, two C-terminal, or all four of the Ca2+ binding loops were substituted by glutamine. The importance of the carbonyl side chain of this glutamic acid to the Ca2+ coordination system was revealed by crystallographic studies of calmodulin (30). As expected, the Ca2+-binding abilities of the mutated sites are completely abolished, based upon the Ca2+ binding induced conformational changes probed by the fluorescent hydrophobic reporter molecule, 9-AC. The results are consistent with the earlier study in which the conserved glutamic acid residue in each individual Ca2+-binding site was mutated (20).

The fluorescence titration results show that the two C-terminal Ca2+-binding sites have a higher affinity for Ca2+ than the two N-terminal sites. The different electrophoretic mobility of calmodulin in the presence of EGTA as compared with Ca2+ also reflects conformational changes upon Ca2+ occupation. The obtained results suggest that the conformational change caused by Ca2+ binding to the two N-terminal sites (E34Q) is different from that caused by Ca2+ binding to the two C-terminal sites (E12Q); occupation of the two C-terminal Ca2+-binding sites has a greater impact on the overall conformational change. This is consistent with the previous findings that the Ca2+ binding at the C-terminal sites of calmodulin induces a larger conformational change (31). Recent structural studies suggest that the C-terminal domain of calmodulin exists in a semi-open conformation in contrast to the close conformation of the N-terminal domain in the absence of Ca2+, and it changes to an open conformation upon Ca2+ binding (32). This may explain the difference of the mobility shift between E12Q and E34Q.

The present results clearly indicate that the effects of Ca2+ on the properties of myosin Ibeta molecule, i.e. the change in actin-activated ATPase activity, actin sliding motor activity, and the dissociation of calmodulin light chains at high Ca2+ concentration are mediated through calmodulin, and that its two high affinity C-terminal Ca2+-binding sites are critical for the regulatory effect of Ca2+.

For myosin Ibeta associated with E12Q, the effects of Ca2+ on actin-activated ATPase activity, motor activity, and the calmodulin dissociation are similar to those for myosin Ibeta associated with wild-type calmodulin. On the other hand, the disruption of the Ca2+-binding sites in the C-terminal domain of calmodulin abolishes the Ca2+ dependence of the ATPase activity, the motor activity of myosin Ibeta , and the dissociation of 1 mol of calmodulin from the heavy chain at above pCa 6. These results suggest that Ca2+ binding to the C-terminal domain of calmodulin, i.e. high affinity Ca2+ binding sites, is responsible for the dissociation of one calmodulin molecule from myosin Ibeta heavy chain. The increase in ATPase activity parallels the dissociation of one molecule of calmodulin according to the Ca2+ dependence data (Fig. 4), thus it is reasonable to conclude that the dissociation of calmodulin increases myosin Ibeta ATPase activity. It should be noted, however, actin independent ATPase activity but not actin dependent activity increases with Ca2+. Similar result has also been found for conventional myosin in which the dissociation of regulatory light chain increases basal myosin ATPase activity (33). It should be noted that while the deletion of the Ca2+ binding at the N-terminal domain of calmodulin did not prevent the dissociation of 1 mol of calmodulin from the heavy chain, it shifted the Ca2+ required for calmodulin dissociation to lower concentration. This result suggests that there is a cross-talk between the N-terminal and C-terminal domains and that deletion of the Ca2+ binding ability at the N-terminal domain of calmodulin affects the conformational change at the C-terminal domain of calmodulin. This is consistent with the earlier finding that conformation of the Tyr-138 in the C-terminal domain of calmodulin is significantly influenced by a change in the Ca2+ binding properties of the N-terminal domain (25).

Clearly, the binding of Ca2+ to calmodulin at the C-terminal sites is critical for the inhibition of actin translocating activity of myosin Ibeta by Ca2+, since this Ca2+-induced inhibition of the motility was not observed with myosin Ibeta containing E34Q or E1234Q calmodulin (Table I). However, it is more complicated to determine whether or not the dissociation of the calmodulin molecule from myosin Ibeta heavy chain is critical for the inhibition of the motor activity. Thus, although the wild-type myosin Ibeta still binds all three calmodulin light chains at pCa 6, its motor activity is completely inhibited at this Ca2+ concentration. One possible explanation is that although the C-terminal domain of the one calmodulin molecule is dissociated from myosin Ibeta heavy chain at pCa 6, the N-terminal domain is still associated with the heavy chain at this Ca2+ concentration, and further conformational change induced by Ca2+ binding at the N-terminal low affinity sites of this molecule is necessary for the complete dissociation (Fig. 5). Presumably, this incomplete association of calmodulin with myosin Ibeta is no longer able to support motor activity. For the E12Q mutant, the conformational change induced by the binding of Ca2+ to the higher affinity sites may be sufficient to dissociate calmodulin from myosin Ibeta heavy chain. It should be noted, however, Ca2+ binding to calmodulin dissociates only one of the three bound calmodulin from myosin Ibeta heavy chain. According to the amino acid sequence, myosin Ibeta has three IQ motifs, one of which is not a completely matched IQ motif, IQXXXRGXXXR (one-letter amino acid code; X is any amino acid residue) (6). It is plausible that the calmodulin bound to the incomplete IQ motif is dissociated from myosin Ibeta when Ca2+ binds to the C-terminal domain. Alternatively, the conformational change in all three calmodulin upon Ca2+ binding to the C-terminal domain results in the inhibition of motility and the additional conformational change upon the Ca2+ binding at the N-terminal low affinity sites destabilizes the association of one of the bound calmodulin to the heavy chain presumably due to steric hindrance. Further studies are needed to clarify the reason why only one molecule of calmodulin is dissociated from myosin Ibeta .


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   Schematic drawing of the regulation of myosin Ibeta . The head-neck domain of myosin Ibeta molecule is shown. A, the third bound calmodulin partially dissociates from the heavy chain at intermediate Ca2+ concentration which results in the loss of motility activity. B, the conformational change in calmodulin at the intermediate Ca2+ concentration is responsible for the loss of motility activity, and the further change in conformation at higher Ca2+ induces the dissociation of a calmodulin from the myosin heavy chain. N and C represent the N and C terminus of calmodulin, respectively.

Studies reported here with mutant calmodulin show that motor function of myosin Ibeta is regulated by Ca2+ binding to the high affinity sites of calmodulin light chains. This regulatory mechanism may also apply to those of other unconventional myosins which contain calmodulin as their light chains.

    ACKNOWLEDGEMENTS

We thank Dr. Yvon Delville (Neuroanatomy Laboratory of Behavioral Neuroscience in the Department of Psychiatry at the Univeristy of Massachusetts Medical Center) for letting us use the densitometry equipment, Vivek Rao for preparation of bacterially expressed mutant calmodulins, and Dr. Shinya Saito for fluorescence measurements.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants AR 41653, HL 47530, and HL 56218 (to M. I.) and National Institutes of Health Grant GM 49155 and R. A. Welch Foundation Grant C-1119 (to K. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Physiology, University of Massachusetts Medical Center, Worcester, MA 01655. Tel.: 508-856-6698; Fax: 508-856-4600; E-mail: Mitsuo.Ikebe{at}ummed.edu.

The abbreviations used are: BBMI, brush-border myosin I; MOPS, 4-morpholinepropanesulfonic acid; 9-AC, 9-anthroylcholine.
    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  1. Mooseker, M., and Cheney, R. E. (1995) Annu. Rev. Cell Dev. Biol. 11, 633-675[CrossRef][Medline] [Order article via Infotrieve]
  2. Pollard, D. P., Doberstein, S. K., and Zot, H. G. (1991) Annu. Rev. Physiol. 53, 653-681[CrossRef][Medline] [Order article via Infotrieve]
  3. Cope, M. J., Whisstock, J., Rayment, I., and Kendrick-Jones, J. (1996) Structure 4, 969-987[Abstract]
  4. Hasson, T., and Moosker, M. S. (1996) J. Biol. Chem. 271, 16431-16434[Free Full Text]
  5. Barylko, B., Wagner, M. C., Reizes, O., and Albanesi, J. P. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 490-494[Abstract]
  6. Zhu, T., and Ikebe, M. (1994) FEBS Lett. 339, 31-36[CrossRef][Medline] [Order article via Infotrieve]
  7. Reizes, O., Barylko, B., Li, C., Sudhof, T. C., and Albanesi, J. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 6349-6353[Abstract]
  8. Ruppert, C., Kroschewski, R., and Bahler, M. (1993) J. Cell Biol. 120, 1393-1403[Abstract]
  9. Wagner, M. C., Barylko, B., and Albanesi, J. P. (1992) J. Cell Biol. 119, 163-170[Abstract]
  10. Sherr, E. H., Joyce, M. P., and Greene, L. A. (1993) J. Cell Biol. 120, 1405-1416[Abstract]
  11. Gillespie, P. G., Wagner, M. C., and Hudspeth, A. J. (1993) Neuron 11, 581-594[Medline] [Order article via Infotrieve]
  12. Assad, J. A., and Corey, D. P. (1992) J. Neurosci. 12, 3291-3309[Abstract]
  13. Zhu, T., Sata, M., and Ikebe, M. (1996) Biochemistry 35, 513-522[CrossRef][Medline] [Order article via Infotrieve]
  14. Wolenski, J. S. (1995) Trends Cell Biol. 5, 310-316[CrossRef]
  15. Cheney, R. E., O'Shea, M. K., Heuser, J. E., Coelho, M. V., Wolenski, J. S., Espreafico, E. M., Forscher, P., Larson, R. E., and Mooseker, M. S. (1993) Cell 75, 13-23[Medline] [Order article via Infotrieve]
  16. Chapman, E. R., Au, D., Alexander, K. A., Nicolson, T. A., and Storm, D. R. (1991) J. Biol. Chem. 266, 207-213[Abstract/Free Full Text]
  17. Maune, J. F, Klee, C. B., and Beckingham, K. (1992) J. Biol. Chem. 267, 5286-5295[Abstract/Free Full Text]
  18. Linse, S., Helmersson, A., and Forsen, S. (1991) J. Biol. Chem. 266, 8050-8059[Abstract/Free Full Text]
  19. Ikura, M. (1996) Trends Biochem. Sci. 21, 14-17[CrossRef][Medline] [Order article via Infotrieve]
  20. Beckingham, K. (1991) J. Biol. Chem. 266, 6027-6030[Abstract/Free Full Text]
  21. Collins, K., Sellers, J. R., and Matsudaira, P. (1990) J. Cell Biol. 110, 1137-1147[Abstract]
  22. Swanljung-Collins, H., and Collins, J. H. (1991) J. Biol. Chem. 266, 1312-1319[Abstract/Free Full Text]
  23. Coluccio, L. M. (1994) J. Cell Sci. 107, 2279-2284[Abstract/Free Full Text]
  24. Wolenski, J. S., Hayden, S. M., Forscher, P., and Mooseker, M. S. (1993) J. Cell Biol. 122, 613-621[Abstract]
  25. Mukherjea, P., Maune, J. F., and Beckingham, K. (1996) Protein Sci. 5, 468-477[Abstract/Free Full Text]
  26. Fabiato, A., and Fabiato, F. (1979) J. Physiol. (Paris) 75, 463-505[Medline] [Order article via Infotrieve]
  27. Ikebe, M., and Hartshorne, D. J. (1985) J. Biol. Chem. 260, 13146-13153[Abstract/Free Full Text]
  28. Sata, M., Matsuura, M., and Ikebe, M. (1996) Biochemistry 35, 11113-11118[CrossRef][Medline] [Order article via Infotrieve]
  29. Keller, C. H., Olwin, B. B., Heideman, W., and Storm, D. R. (1982) in Calcium and Cell Function (Cheung, W. Y., ed), Vol. 3, pp. 103-127, Academic Press, New York
  30. Babu, Y. S., Bugg, C. E., and Cook, W. J. (1988) J. Mol. Biol. 204, 191-204[Medline] [Order article via Infotrieve]
  31. Klee, C. B. (1988) Mol. Asp. Cell. Regul. 5, 35-56
  32. Swindell, M. B., and Ikura, M. (1996) Nat. Struct. Biol. 3, 501-504[Medline] [Order article via Infotrieve]
  33. Lowey, S., Waller, G. S., and Trybus, K. M. (1993) Nature 365, 454-450[Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.